Comparison of tilmicosin and gamithromycin for treatment of undifferentiated fever in backgrounded winter-placed feedlot calves

Authors

  • Joyce Van Donkersgoed Alberta Beef Health Solutions Inc., Box 307, Picture Butte, Alberta, TOK 1V0, Canada
  • John K. Merrill Elanco, Division Eli Lily Canada Inc., 150 Research Lane, Guelph, Ontario, NIG 4T2, Canada
  • Steve Hendrick Western College of Veterinary Medicine, Saskatoon, Saskatchewan S7N 5B4, Canada

DOI:

https://doi.org/10.21423/bovine-vol47no1p15-21

Keywords:

bovine respiratory disease, undifferentiated fever, tilmicosin, gamithromycin

Abstract

A study was conducted in Alberta, Canada utilizing 2 feedlots to compare clinical efficacy of tilmicosin to gamithromycin for the initial treatment of undifferentiated fever in backgrounded winter-placed feedlot calves. There were no significant differences (P>0.05) in undifferentiated fever relapse rates and crude case fatality or bovine respiratory disease/histophilus fatality rates between the 2 treatments. As a result, the cost-benefit was based on the difference in treatment cost between the 2 drugs. Using current drug costs and a treatment weight of 750 lb (340 kg), tilmicosin had an economic advantage of $2.23CAN per head over gamithromycin.

Cover image of Volume 47, No.1 of the Bovine Practitioner: a photo of Angus cattle grazing in a field of wildflowersalongside a muddy pool of water. In the background, some cattle are wading through the water and others are grazing on green fields that roll gently up to the horizon.

Downloads

Published

2013-02-01

Issue

Vol. 47, No. 1 (2013 Spring)

Section

Articles

How to Cite

Comparison of tilmicosin and gamithromycin for treatment of undifferentiated fever in backgrounded winter-placed feedlot calves. (2013). The Bovine Practitioner, 47(1), 15-21. https://doi.org/10.21423/bovine-vol47no1p15-21

Most read articles by the same author(s)